Literature DB >> 3548334

Sex differences in the coronary heart disease risk profile: a possible role for insulin. The Beaver County Study.

R P Donahue, T J Orchard, D J Becker, L H Kuller, A L Drash.   

Abstract

The mortality rate from coronary heart disease is much higher among men than women except in diabetes mellitus, which appears to reduce this sex difference. It is hypothesized that the female advantage is due, at least partly, to the more efficient insulin mediated glucose homeostasis in females, an advantage lost in the diabetic state. The authors studied 170 young adult men and women aged 20-24 years from a population-based survey in Beaver County, Pennsylvania, in 1981-1982, in an attempt to further elucidate the sex-specific relationships between fasting serum insulin concentrations and several risk factors. Women who used oral contraceptives and subjects whose fasting serum glucose exceeded 110 mg/dl were excluded. Insulin was related to body mass index in both sexes (r = 0.31; p less than 0.01 for men; r = 0.26, p less than 0.01 for women) and to systolic blood pressure (r = 0.27, p less than 0.01 for men; r = 0.36, p less than 0.001 for women). Insulin was related to diastolic blood pressure in men only (r = 0.31, p less than 0.05). Multivariate analysis revealed fasting serum insulin to be an independent predictor of systolic blood pressure in both sexes and of diastolic blood pressure in men only. Insulin was inversely related to high density lipoprotein cholesterol only among men and this relationship appeared to be largely independent of body mass index and triglycerides. Results indicate that insulin concentration is associated with an adverse coronary heart disease risk factor profile especially among men, consistent with their excess risk of cardiovascular disease.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3548334     DOI: 10.1093/oxfordjournals.aje.a114578

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  9 in total

Review 1.  Sex-related differences in the insulin resistance syndrome.

Authors:  D B Corry
Journal:  Curr Hypertens Rep       Date:  2001-04       Impact factor: 5.369

2.  Is insulin atherogenic?

Authors:  T J Orchard
Journal:  Diabetologia       Date:  1988-06       Impact factor: 10.122

Review 3.  Impaired estrogen receptor action in the pathogenesis of the metabolic syndrome.

Authors:  Andrea L Hevener; Deborah J Clegg; Franck Mauvais-Jarvis
Journal:  Mol Cell Endocrinol       Date:  2015-05-29       Impact factor: 4.102

Review 4.  Role of hypertension in the metabolic syndrome: who is affected?

Authors:  Gladys Velarde; Bradford C Berk
Journal:  Curr Hypertens Rep       Date:  2005-12       Impact factor: 5.369

Review 5.  Unmet needs among patients with type 2 diabetes and secondary failure to oral anti-diabetic agents.

Authors:  D Pitocco; D Valle; A Rossi; R Gentilella
Journal:  J Endocrinol Invest       Date:  2008-04       Impact factor: 4.256

Review 6.  Sexual differences in the control of energy homeostasis.

Authors:  Haifei Shi; Randy J Seeley; Deborah J Clegg
Journal:  Front Neuroendocrinol       Date:  2009-03-31       Impact factor: 8.606

7.  Are gender differences in cardiovascular disease risk factors explained by the level of visceral adipose tissue?

Authors:  S Lemieux; J P Després; S Moorjani; A Nadeau; G Thériault; D Prud'homme; A Tremblay; C Bouchard; P J Lupien
Journal:  Diabetologia       Date:  1994-08       Impact factor: 10.122

Review 8.  The link between insulin resistance and hypertension. Effects of antihypertensive and antihyperlipidaemic drugs on insulin sensitivity.

Authors:  T Baba; S Neugebauer
Journal:  Drugs       Date:  1994-03       Impact factor: 9.546

Review 9.  The role of estrogens in control of energy balance and glucose homeostasis.

Authors:  Franck Mauvais-Jarvis; Deborah J Clegg; Andrea L Hevener
Journal:  Endocr Rev       Date:  2013-03-04       Impact factor: 19.871

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.